F605, F756 and F757 Citations by State: CMS Survey Data, 2025 to 2026

What this page is

A dated count of three survey tags that matter to consultant pharmacists, built from CMS's public Health Deficiencies dataset: F605 (chemical restraints and, since April 2025, unnecessary psychotropic medication), F756 (the monthly drug regimen review) and F757 (unnecessary drugs). CMS publishes one row per citation with the facility, survey date, tag, scope and severity. Pharmacore filters it to these tags, counts by state and by month, and republishes the counts here each month with the source window. The F758 page explains why the April 2025 date matters.

F758 stopped, F605 started

The monthly counts show the change in surveyor practice. F758 citations end in May 2025 and F605, which carried single-digit monthly counts before, takes their place from the same month. Survey dates in the most recent two to three months are still being processed by CMS, so the last rows understate the final totals.

Citations by state, 28 April 2025 to 30 June 2026

The fifteen states with the most citations across the three tags. Counts are citations, not facilities; a facility cited at two surveys appears twice. Larger states have more facilities, so a high count is not by itself a sign of weaker practice.

Every state and territory is in the download: citations by state (CSV) and citations by month (CSV). Both carry the source and the date window in every row.

Severity

Most citations under these tags are scope and severity D or E, meaning no actual harm with potential for more than minimal harm. In the window above, D and E make up 99% of F605 citations, 98% of F756 and 98% of F757. Citations at G or above (actual harm) are rare but present for each tag.

Method

• Source: CMS Provider Data Catalog, Health Deficiencies, dataset r5ix-sfxw, the version published on 1 August 2026 (CMS states it covers citations from the last three years).
• Filter: deficiency tag number 0605, 0756, 0757 and 0758, read through the dataset's public API on 6 October 2026.
• Window: survey dates from 28 April 2025 (implementation of QSO-25-14-NH) to 30 June 2026. The monthly table starts in January 2025 to show the change.
• Counts are citations as published, including those under informal dispute resolution. Corrections and dispute outcomes are not applied.
• Refresh: monthly, after CMS publishes. Each refresh replaces this page and the CSVs and updates the dates above.

What a consultant pharmacist can take from it

F605 is now the tag where psychotropic findings land, and since May 2025 it has been cited more often each month than either F756 or F757. Recommendations that still cite F758 should be updated. The F605 page sets out what surveyors look for; the F756 page covers the monthly review itself.

Related reference pages

• What replaced F758?
• F605: chemical restraints and psychotropic medication
• F756: the monthly medication regimen review
• F757: unnecessary drugs

Sources

• CMS Provider Data Catalog: Health Deficiencies (dataset r5ix-sfxw)
• CMS, QSO-25-14-NH: Revised Long-Term Care Surveyor Guidance (revised 10 March 2025)
• CMS State Operations Manual, Appendix PP, Guidance to Surveyors for Long Term Care Facilities (Rev. 232)

Data pulled and checked against these CMS sources on 6 October 2026. This page summarizes federal guidance for orientation. It is not legal or clinical advice; read the source documents and your state requirements before acting on it.

Pharmacore is software for consultant pharmacists, built by pharmacists, for pharmacists. The software suggests, the pharmacist decides. Book a demo to see how it supports the monthly review.